New Drug-Radiation combo tested in fight against tough pancreatic cancer
NCT ID NCT04331041
Summary
This study is testing if adding an experimental drug called defactinib to a precise form of radiation therapy (SBRT) can better control advanced pancreatic cancer that cannot be surgically removed. After initial chemotherapy, 42 participants will be assigned to receive either the radiation-drug combination or radiation alone. Researchers will primarily track how long patients live without their cancer getting worse and monitor side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.